Total Payments
$98,680
2024 Payments
$18,103
Companies
7
Transactions
183
Medicare Patients
1,843
Medicare Billing
$258,726
Payment Breakdown by Category
Other$67,625 (68.5%)
Consulting$15,500 (15.7%)
Travel$7,780 (7.9%)
Food & Beverage$5,837 (5.9%)
Research$1,878 (1.9%)
Education$59.21 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,175 | 34 | 63.0% |
| Consulting Fee | $15,500 | 9 | 15.7% |
| Travel and Lodging | $7,780 | 35 | 7.9% |
| Food and Beverage | $5,837 | 95 | 5.9% |
| Honoraria | $5,450 | 2 | 5.5% |
| Unspecified | $1,878 | 6 | 1.9% |
| Education | $59.21 | 2 | 0.1% |
Payments by Type
General
$96,802
177 transactions
Research
$1,878
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $49,889 | 71 | $0 (2022) |
| ABBVIE INC. | $32,850 | 37 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $11,045 | 37 | $0 (2020) |
| Ipsen Biopharmaceuticals, Inc | $2,030 | 10 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $1,614 | 18 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $1,117 | 9 | $0 (2024) |
| Abbott Laboratories | $135.20 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,103 | 34 | ABBVIE INC. ($16,172) |
| 2023 | $10,827 | 14 | AbbVie Inc. ($10,395) |
| 2022 | $10,552 | 19 | ABBVIE INC. ($6,283) |
| 2021 | $11,306 | 23 | Allergan, Inc. ($9,419) |
| 2020 | $4,301 | 14 | Allergan, Inc. ($3,963) |
| 2019 | $18,962 | 33 | Allergan Inc. ($10,067) |
| 2018 | $9,734 | 21 | Allergan Inc. ($9,041) |
| 2017 | $14,896 | 25 | Allergan Inc. ($13,553) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $482.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $201.52 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $115.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $170.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Merz Pharmaceuticals, LLC | — | Travel and Lodging | In-kind items and services | $534.96 | General |
| 06/19/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Travel and Lodging | In-kind items and services | $239.70 | General |
| Category: Musculoskeletal | ||||||
| 04/24/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $787.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $434.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $357.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $28.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Neurology | ||||||
| 03/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $99.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Musculoskeletal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NT 201 IN THE TREATMENT OF LOWER LIMB SPASTICITY CAUSED BY STROKE OR TRAUMATIC BRAIN INJURY IN ADULT SUBJECTS, FOLLOWED BY AN OPEN LABEL EXTENSION WITH OR WITHOUT COMBINED UPPER LIMB TREATMENT | Merz North America, Inc. | $1,878 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 405 | 861 | $186,088 | $53,287 |
| 2022 | 10 | 401 | 893 | $185,878 | $51,797 |
| 2021 | 11 | 493 | 1,173 | $240,565 | $70,454 |
| 2020 | 11 | 544 | 1,463 | $281,015 | $83,187 |
Total Patients
1,843
Total Services
4,390
Medicare Billing
$258,726
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 182 | 455 | $81,732 | $27,555 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 78 | $27,678 | $7,419 | 26.8% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 24 | 62 | $22,886 | $4,555 | 19.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $11,976 | $3,194 | 26.7% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 11 | 36 | $12,168 | $2,640 | 21.7% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 14 | 40 | $8,920 | $1,930 | 21.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 30 | 30 | $5,420 | $1,844 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 26 | $6,364 | $1,636 | 25.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 33 | 98 | $4,900 | $1,316 | 26.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,044 | $1,198 | 29.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 171 | 491 | $87,889 | $26,692 | 30.4% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 23 | 67 | $23,611 | $5,132 | 21.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 32 | $15,968 | $4,625 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 39 | $13,809 | $4,294 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 56 | $13,504 | $3,689 | 27.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 12 | 27 | $9,126 | $1,854 | 20.3% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 15 | 39 | $8,983 | $1,848 | 20.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 32 | 32 | $5,696 | $1,714 | 30.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 32 | 94 | $4,700 | $1,231 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 16 | $2,592 | $719.64 | 27.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 169 | 684 | $122,436 | $37,581 | 30.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 64 | 65 | $32,435 | $9,933 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 74 | $15,938 | $4,792 | 30.1% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Office | 2021 | 23 | 61 | $20,618 | $4,718 | 22.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 46 | 48 | $8,544 | $2,639 | 30.9% |
About Dr. Joseph Burris, MD
Dr. Joseph Burris, MD is a Physical Medicine & Rehabilitation healthcare provider based in Columbia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093744690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Burris, MD has received a total of $98,680 in payments from pharmaceutical and medical device companies, with $18,103 received in 2024. These payments were reported across 183 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,175).
As a Medicare-enrolled provider, Burris has provided services to 1,843 Medicare beneficiaries, totaling 4,390 services with total Medicare billing of $258,726. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Columbia, MO
- Active Since 07/03/2006
- Last Updated 10/05/2022
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1093744690
Products in Payments
- BOTOX (Biological) $69,240
- BOTOX (Drug) $9,950
- XEOMIN (Biological) $9,908
- BOTOX NEURO REHAB (Drug) $3,535
- Xeomin (Biological) $2,217
- DYSPORT (Drug) $1,783
- Zilretta (Drug) $1,117
- Dysport 300 U-1 (Drug) $204.77
- PROCLAIM (Device) $135.20
- Dysport (Drug) $42.30
- BOTOX THERAPEUTIC (Biological) $13.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Columbia
Reza Farid, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $105,941
Physical Medicine & Rehabilitation $105,941
Jane Emerson, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $65,515
Physical Medicine & Rehabilitation $65,515
Dr. Vovanti Jones, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $9,228
Physical Medicine & Rehabilitation $9,228
Ryan Castoro, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $7,073
Physical Medicine & Rehabilitation $7,073
Rachael Brashears, D.o., Mba, D.O., MBA
Physical Medicine & Rehabilitation — Payments: $6,292
Physical Medicine & Rehabilitation $6,292
Dr. Erik Ensrud, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,800
Physical Medicine & Rehabilitation $4,800